CMS certification 060107
National Jewish Health
1400 Jackson St, Denver, CO 80206
CMS does not publish an overall star rating for National Jewish Health. On all 3 death, complication, infection and readmission measures CMS could compare, it is no different from the national rate.
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
How National Jewish Health compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| National Jewish HealthThis hospital | Not rated | — | — | No different |
| Denver Health & Hospital AuthoritySame city | 3/5 | 72% | 3 h 28 min | 1 better 1 worse |
| AdventHealth PorterSame city | 4/5 | 65% | 3 h 19 min | 4 better |
| HCA HealthOne Presbyterian St. LukesSame city | 2/5 | 69% | 2 h 1 min | 1 better 2 worse |
| Saint Joseph HospitalSame city | 5/5 | 80% | 2 h 45 min | 3 better |
| HCA Healthone RoseSame city | 4/5 | 75% | 2 h 10 min | 1 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Denver.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Pressure ulcers (bed sores) 37 cases | No different | 0.62 per 1,000 likely 0 per 1,000 – 1.96 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 38 cases | No different | 0.21 per 1,000 likely 0 per 1,000 – 0.45 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 39 cases | No different | 0.27 per 1,000 likely 0.05 per 1,000 – 0.49 per 1,000 | 0.27 per 1,000 |
10 more measures had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Unplanned visits after an outpatient colonoscopy 464 cases | No different | 14.3 per 1,000 likely 10.9 per 1,000 – 19 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 85 cases | No different | 9.6 per 100 likely 6.9 per 100 – 13.4 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 85 cases | No different | 4.9 per 100 likely 3.2 per 100 – 7.4 per 100 | 5.4 per 100 |
11 more measures had too few cases here to report.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, infections caught in the hospital. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Clinicians registered at this address
349 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 13 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Pulmonary Disease | 73 |
| Allergy & Immunology | 19 |
| Internal Medicine | 14 |
| Pediatrics | 14 |
| Critical Care Medicine | 12 |
| Physician Assistant | 12 |
| Family | 11 |
| Registered Nurse | 11 |
| Rheumatology | 11 |
| Cardiovascular Disease | 10 |
| Adult Health | 9 |
| Nurse Practitioner | 9 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2020 $5.1M
- 2021 $7M
- 2022 $6.6M
- 2023 $6.2M
- 2024 $8.1M
- 2025 $6.2M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $3.1M | 17 |
| Speaking, teaching and other services | $626,984 | 42 |
| Space rental and facility fees | $91,375 | 19 |
| Charitable contributions | $61,500 | 3 |
| Gifts | $50,000 | 2 |
| Royalties and licensing fees | $43,352 | 24 |
| Consulting fees | $10,851 | 3 |
| Education | $10,500 | 3 |
| Debt forgiveness | $1,078 | 2 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1.4M | 16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1M | 52 |
| Insmed, Inc. | $830,534 | 26 |
| Novartis Pharmaceuticals Corporation | $505,230 | 3 |
| Alexion Pharmaceuticals, Inc. | $339,716 | 34 |
| Genentech, Inc. | $235,356 | 10 |
| Genzyme Corporation | $225,797 | 25 |
| E.R. Squibb & Sons, L.L.C. | $192,346 | 3 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| Effect of Omalizumab in the Skin of Food Allergy Patients Genentech, Inc. | $216,293 |
| A Two-year, Phase 4, Open-label, Single-arm Treatment Study to Evaluate the Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Parti… GENZYME CORPORATION · NCT05983068 | $181,496 |
| Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immunoglobulin, HIZENTRA) in Post-… CSL Behring · NCT06524739 | $166,982 |
| Evaluation of short-term change in quantitative CT as a marker of progressive pulmonary fibrosis Boehringer Ingelheim Pharmaceuticals, Inc. | $157,974 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis E.R. Squibb & Sons, L.L.C. | $157,561 |
| An open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally in patients with idiopathic pulmonary fibrosis (IPF) an… Boehringer Ingelheim Pharmaceuticals, Inc. | $92,832 |
| A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis VERTEX PHARMACEUTICALS INCORPORATED | $79,411 |
| A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonar… United Therapeutics Corporation · NCT04708782 | $69,404 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about National Jewish Health
Is National Jewish Health a good hospital?
CMS does not publish an overall star rating for National Jewish Health. On all 3 death, complication, infection and readmission measures CMS could compare, it is no different from the national rate. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Does National Jewish Health have an emergency room?
Yes. CMS lists emergency services at National Jewish Health.
Does National Jewish Health receive money from drug and device companies?
Drug and device makers reported $6.2M in payments to National Jewish Health for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.